Purpose: Prenatal genetic carrier screening can identify parents at risk of having a child 1 4 affected by a recessive condition. However, the conditions/genes most appropriate for 1 5 screening remain a matter of debate. Estimates of carrier rates across genes are 1 6 needed to guide construction of carrier screening panels.
We extracted a list of 924 genes previously annotated as being associated with 1 0 3 severe Mendelian conditions 13 . Among these 924 genes, we included the 416 genes 1 0 4 that are annotated as acting in an autosomal recessive manner 8 . These calculations were performed separately for each ancestry. calculations were performed separately for each ancestry. We also calculated the at-risk couple rate (ACR), which is the proportion of Mendelian condition. These individuals were sequenced across many different 1 4 7 sequencing platforms and at different centers, but the sequencing data underwent The samples in gnomAD are distributed across 7 major ancestries: European (NFE, n=55860), and South Asian (SAS, n=15391). We did not include the 1 5 3
Finnish in this study since they comprise a small proportion of the US population. We We then used these VCRs to generate estimates of gene carrier rates (GCRs) 1 5 7
for each gene, which is the estimated proportion of individuals who carry one or more 1 5 8 pathogenic or likely pathogenic variants in that gene. Using these GCRs, we also 1 5 9 calculated cumulative carrier rates (CCRs) for various sets of genes. These sets of 1 6 0 genes are based on thresholds (e.g., genes having a GCR greater than a given see Figure 1 for a depiction of our workflow. The GCR for each of the 416 genes associated with severe recessive Mendelian 1 6 6
conditions for each of the 6 ancestries as well as the US composite are listed in Table   1 6 7 S2. For illustrative purposes, Figure 2 shows the ten highest GCRs for each of the 6 1 6 8 ancestry groups. Across ancestries, the highest GCR for a single gene is 12.0% for 1%. In contrast, in AMR, only 6 of the 416 genes had a GCR > 1%. In Figure S1 , we show the top 30 genes in terms of GCR in any ancestry and 1 7 4
show the carrier rates across ancestries for each of these genes. As can be seen, some 1 7 5 genes such as HBB or F11 are relatively restricted to a single population (AFR and ASJ 1 7 6 respectively). In contrast, other genes such as CYP21A2 have high GCRs across many 1 7 7
ancestries. Cumulative Carrier Rates
We ranked each gene in descending order by its GCR in the respective ancestry 1 8 1 and plotted the CCRs as increasing numbers of genes are screened. As can be 1 8 2 appreciated in Figure 3A , there is initially a rapid increase in the CCR, reflecting a small 1 8 3 number of genes with high GCRs. This is then followed by a long tail of genes which 1 8 4 contribute asymptotically to the CCR. For example, in ASJ, 90% of the CCR is 1 8 5 contributed by the 45 top ranking genes with the highest GCR (out of 416 total genes).
8 6
We next calculated CCRs for various sets of genes, which are delineated to 1 8 7 reflect the hypothetical construction of an ECS panel. We first examined the CCR of all 1 8 8 416 severe recessive genes. As can be appreciated in Figure 3B , there were very high 1 8 9
CCRs for this set of 416 genes in all ancestries (red bars). At the extreme, in ASJ, the 1 9 0 CCR across all 416 genes was 65.0%. The lowest CCR for the 416 genes was in EAS 1 9 1 at 36.5%.
The American College of Obstetrics and Gynecology (ACOG) recently suggested 1 9 3 that genes with GCR > 1.0% are appropriate for ECS. We thus examined how 1 9 4
screening only genes with GCR > 1% in the respective population would affect the 1 9 5
CCR. We found that setting this >1% threshold drastically reduces the CCR by 20.1-1 9 6
55.8% (purple bars) ( Figure 3B ). We also show CCRs if only genes with GCR > 0.5% 1 9 7 (blue bars) or > 0.1% (green bars) are included ( Figure 3B ). We note that these results 1 9 8 simulate the yields that would be derived from using a hypothetical ancestry-specific 1 9 9 ECS panel, where only genes with GCR greater than some threshold based on that 2 0 0 ancestry are included on the panel. We next examined the number of genes that meet the 1.0% GCR threshold in 2 0 4 the respective ancestry. We found that in ASJ, 30 genes had GCR > 1.0 %, while in genes that need to be screened. The previous analyses ( Figure 3 ) defined hypothetical ECS panels using GCR We next calculated the CCR for each pan-ethnic panel and compared it to 2 2 0 ancestry-specific panels ( Figure 4B-D) . Figure 4B shows the CCRs for a hypothetical designed to capture genes with GCR > 0.5% ( Figure 4C ) and for GCR > 0.1% ( Figure   2 2 4 4D). At-risk couple rate 2 2 7
We examined the at-risk couple rate (ACR) for all 416 genes, which is the 2 2 8 probability that both the mother and father are carriers for pathogenic or likely 2 2 9 pathogenic variants in the same gene. Unsurprisingly, the highest ACRs for intra-2 3 0 ancestry couples was in ASJ (280 out of 10,000 couples) and the lowest was for AMR 2 3 1 (47 out of 10,000 couples ( Figure 5A ). The inter-ancestry rates ranged from 40 out of 2 3 2 10,000 EAS/NFE couples, to 105 out of 10,000 NFE/ASJ couples.
3 3
We also calculated the ACR when considering only genes with GCR > 1.0% in 2 3 4 any population ( Figure 5A ), GCR > 0.5% ( Figure 5C ), or GCR > 0.1% ( Figure 5D ), 2 3 5 reflecting the ACR that would result from the application of various hypothetical pan-2 3 6 ethnic panels highlighted in Figure 4 . Strikingly, the yields in terms of ACR for screening 2 3 7 just the 47 genes with GCR > 1.0% are very close to the yields of screening all 416 2 3 8 genes (compare Figure 5A with Figure 5B ). In fact, screening just these 47 genes would 2 3 9
identify at least 85% of the at-risk couples that screening all 416 genes would identify. across ancestries, including 65% in ASJ. We found that the proportion of at-risk couples 2 4 7 was comparatively lower, ranging from 0.4-2.8% of couples.
4 8
Our study has important implications for the design of ECS panels. First, we comprehensive in terms of the variants examined in the targeted genes. Other studies 3 0 0
have been more comprehensive in terms of variants and genes analyzed, but have There are several important limitations to our study. First, we only examined 3 0 5 coding variants in autosomal recessive genes. Our study cannot be extended to genes 3 0 6
acting through alternative modes of inheritance, such as X-linked recessive. We also 3 0 7
could not reliably examine more complex forms of genetic variation, such as CNVs only include variants annotated as likely pathogenic or pathogenic in ClinVar 8, 9, 11 .
3 1 8
Some of these variants are actually benign, while there may be others that we did not 3 1 9
include that are actually pathogenic 20,21 . This is an issue that is well beyond the scope 3 2 0 of this work. In summary, our work informs the selection of genes that should be considered facilitates counseling of patients as they consider PGCS. Each gene has between 2-4 variants, each with an associated variant carrier rate (VCR). The 4 0 6 gene carrier rate (GCR) for each gene is then the probability that an individual will carry at least 0.5% (blue), or > 1.0% (purple). genes with GCR > 1.0% (B), > 0.5% (C), or > 0.1% (D). the GCR. Each gene has six points, representing the GCR for each of six ancestries. (GCR)   HBB  ABCC6  XPC  NPHS2  ACADS  CFTR  CYP21A2  CEP290  SMN1  EVC  CYP21A2  CFTR  GJB2  ABCC6  PAH  ATP7B  TYR  MMACHC  GAA  CEP290  F11  CYP21A2  TYR  PAH  CFTR  ACADS  TNXB  HEXA  ABCC6  SLC3A1  ABCC6  CYP21A2  SRD5A2  NPHS1  GJB2  ATP7B  SLC26A4  CEP290  USH2A  HBB  CYP21A2  CFTR  GJB2  PAH  ABCC6  ACADM  TYR  PMM2  DHCR7  GNRHR  CYP21A2  CFTR  ABCC6  HBB  GJB2  ERCC2  NPHS2  RPGRIP1L  CEP290  PAH  CYP21A2  CFTR  ABCC6  GJB2  HBB  PAH  TYR  ACADM  PMM2 
